ABBVIE INC. (ABBV)
Clinical trial NCT06461897 updates: 1. completion date: 2029-11-01 → 2030-07-01 2. primary completion date: 2029-11-01 → 2030-07-01
Clinical trial NCT06461897 updates: 1. completion date: 2029-11-01 → 2030-07-01 2. primary completion date: 2029-11-01 → 2030-07-01
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical